Melanoma: Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients

Final results from a Phase III trial of a new treatment called percutaneous hepatic perfusion in patients with melanoma of the eye (ocular or uveal melanoma) have demonstrated that it significantly extends the time patients can live without the disease progressing.